GCS 16
  • home page
  • Paediatrics
    • Paediatric fracture management
    • Procedural sedation
  • fellowship examination
  • study tips

Amal Mattu's 'Must-Read' EM Articles of 2015

23/1/2016

0 Comments

 
From Medscape (7.1.16, open access, click to open) - Amal Mattu’s "Three Must-Read Emergency Medicine Articles of 2015”. 

The first two are practice changing articles and well worth a read:
  • Cardiac Arrest: A Treatment Algorithm for Emergent Invasive Cardiac Procedures in the Resuscitated Comatose Patient.
  • Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians.

The issue of using age-adjusted D-dimer threshold (top normal level = age × 10 ng/mL rather than a generic 500 ng/mL cutoff) for patients older than 50 years, comes up again and appears to be the way to go. I am not sure how to use this in the Australian setting as we have cutoffs which differ between hospitals. 

Enjoy,

Danny

Danny Ben-Eli, BSc, MD, FACEM
​Emergency Physician


0 Comments

CVC Complications By Site Of Insertion - More Evidence Supporting Subclavian CVCs

16/1/2016

0 Comments

 
Dedicated to Richar Haydon.

A 2012 study published in Critical Care Medicine caused a huge change in views on use of femoral CVCs as it showed that blood steam infection rates were not higher using this site. 

A recent French RCT published in the NEJM in September 2015 (and reviewed this week in Medscape), compared complications of CVC insertion in the 3 most commonly used sites - Internal Jugular (IJ), Subclavian (SC) and Femoral (F). 

This multi-centre study was not a small. It involved 3471 catheters inserted in 3027 patients, in 10 ICUs  (in 9 hospitals) over a 2.5 year period. 

The primary outcome measure was a composite of catheter-related bloodstream infection and symptomatic deep-vein thrombosis (they also looked at the incidence of pneumothorax).

The risk for the primary outcome was similar in the F and IJ groups (hazard ratio [HR], 1.3; P = 0.30) and significantly higher in both F and IJ groups compared with the SC group (HR, 3.5 and 2.1, respectively). Pneumothorax requiring a chest tube was associated with 1.5% of SC vein insertions and 0.5% of IJ vein insertions. 

The bottom line:
Overall, SC vein catheterisation was associated with a lower risk for catheter-related bloodstream infection and symptomatic DVT, and a higher risk for pneumothorax, than IJ or F vein catheterisation.

Personally, especially in my retrieval work, where the risk of pneumothorax can have devastating consequences, I will continue to use the Femoral vein where possible (the list of exclusions would be long - severe hypovolemic shock in trauma, beriatric patients and site infection / irritation, to mention a few). A Femoral CVC can be changes to SC CVC once the patient is in ICU and there is less time pressure. 

Enjoy,

Danny Ben-Eli
​@danbeneli
Emergency Physician
0 Comments

Intra-Arterial Treatment For Stroke - A Year In Review And A Time For Change?

6/1/2016

0 Comments

 
Picture


For years, Emergency Medicine has been at odds with Neurology's use of Intravenous Thrombolytics for management of acute stroke. This criticism was based on:  
- Multiple published negative trials, not demonstrating benefit and some showing harm.
- Neurology’s eagerness to use an industry sponsored, single “positive” study - the NINDS trial (published in 1995),
   as proof of benefit using IV thrombolytics for acute stroke. This was despite a reanalysis of the trial's raw data
   (obtained after a freedom-of-information claim by an American Emergency Physician - Jerome Hoffman),
   demonstrating significant flaws.

The use of CT-Perfusion imaging to guide therapeutic interventions (based on a vascular penumbra around the infarcted area), and the increasing use of Intra-Arterial Treatment for acute stroke, can probably now be considered evidence-based. 

Intra-arterial therapy can be broadly divided into: 
- Chemical dissolution of clots with locally delivered thrombolytic agents.
- Clot retrieval or thrombectomy with mechanical devices.

Four studies published over the last year have changed my opinion on the dreaded topic of “thrombolysis in stroke” (they can be downloaded below):

1. Published in January 2015, the MR CLEAN study (n=500, in the Netherlands) demonstrated that:
   - In patients with acute ischemic stroke caused by a proximal intracranial occlusion of the anterior circulation.
   - Intra-arterial treatment administered within 6 hours after stroke onset was effective and safe.

2. The EXTEND-IA study, published in March 2015, was stopped early because of efficacy, after 70 patients had
   undergone randomisation: 
   - The percentage of ischemic territory that had undergone reperfusion at 24 hours was greater in the
     endovascular-therapy group than in the alteplase-only group. 
   - The authors (including four from the MMC Stroke Unit) concluded that in patients with ischemic stroke with a
     proximal cerebral arterial occlusion and salvageable tissue on CT perfusion imaging, early thrombectomy with
     the Solitaire FR stent retriever, as compared with alteplase alone, improved reperfusion, early neurologic  
     recovery, and functional outcome. (Funded by the Australian NHMRC).

3. November 2015, saw the publication of a meta-analysis of 8 randomised clinical trials (n=2423) of
   endovasculartherapy with mechanical thrombectomy vs standard medical care (which includes the use of tPA).
   The authors concluded that: 
   - Among patients with acute ischemic stroke, endovascular therapy with mechanical thrombectomy was
     associated with improved functional outcomes and higher rates of angiographic revascularisation. 
   - There was no significant difference in symptomatic intracranial hemorrhage or all-cause mortality at 90 days.

4. A further analysis of data from MR CLEAN, published in December 2015, demonstrated that:
   - For every hour of reperfusion delay, the initially large benefit of intra-arterial treatment (IAT) decreases. 
   - The absolute risk difference for a good outcome was reduced by 6% per hour of delay. 
   - The authors conclude that patients with acute ischemic stroke require immediate diagnostic workup and IAT. 


With the increasing availability of CT-Perfusion to guide if and which therapy acute stroke patients receive, we have now probably moved beyond those initial disagreements. The role of Emergency Medicine in identifying acute stroke patients and facilitating rapid transfer to CT-Perfusion and interventional neuro-radiology, is pivotal. 

It is now time to work together with our neurology colleagues to ensure our acute stroke patients receive evidence based imaging and treatment, and achieve the best possible outcomes for a condition which would otherwise be devastating.

Will 2016 be The Year of the Stroke? 

Danny

Dr D. Ben-Eli, BSc, MD, FACEM
​

Article1
Article 3
Article 2
Article 4
0 Comments

    Archives

    December 2017
    December 2016
    October 2016
    September 2016
    August 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015

    Categories

    All

    RSS Feed

Proudly powered by Weebly